Arbor Life Labs has technology that regulates the Wnt/?-Catenin pathway complemented by modulating disease and tissue specific molecular targets. We develop regenerative medicine therapeutics to address dermatology conditions, degenerative diseases and immune conditions. Arbor’s dermatology platform ALRV5XR, sets a new standard of care for Androgenic Alopecia in women and men. Our addressable market exceeds $500 Billion with rapid time to commercialization by following a non-drug regulatory pathway.

Arbor Life Labs Logo



Event details

Date: June 8 - 12, 2020

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


34 in total